RE:I,m always think--here,s what I,m thinking---replys welcome-Impalaman wrote: What is going to give us more bang for the buck---giving a NR.for a 2 patient update early in January--or waiting to annonce a 5 patient update 1-march--before the AUA meeting--and before the 0.54 warrant expiry----they could give an update on the first 2 if their cancer free---but what if there is 1 that,s not----if that,s the case they would be better of waiting for all 5 results---4 out of 5 gives you an 80% CR----if all are CR---that,s even better----they could be playing it cautiously--sure we have to wait longer ---but maybe that,s a smarter thing to do----if that,s what the boys are thinking (the above)Than maybe the first NR. will be the FDA approval----that should take us to 0.70-0.80----then a Halt --in early march for 5 patient results--hopefully 80-100%----and heavy institutional buying will take us to 3.00-5.00---I,m sure a few of you would be infavor of 2 P results now----BUT---BUT---BUT--BUT--do you see my point---they did say they would not be releasing Nr's one at a time --like in PH1--bundling them in PH2.
Im in favour of whatever strategy gets us to said $3-5 in Q1 in whatever order, news release or which way the dance is executed.
The pinballs are locked in for a multiball.
Would be real sweet to get the ORF Research concluded from June 28/2018... surely getting Cervical, Colon and Throat are much less challenging than the Brain and Lung...... anyone that opens an anatomy textbook knows what I mean.
Would again solidify us as Phase 1 ready for multi-indication heading into January so when the IND comes.. Theralase is in full position for any Off-Book use and Right to Try with Phase 1 ready indications.
Cleaning up our house before 90 day marks.. would be most impressive.
IMHO